Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test
- PMID: 25954485
- PMCID: PMC4419049
Using recombinant Chlamydia trachomatis OMP2 as antigen in diagnostic ELISA test
Abstract
Background and objectives: The obligate intracellular bacterium Chlamydia trachomatis causes sexually transmissible diseases in human. Timely and sensitive detection of this pathogen is very important. There are many cross-reactions in bacteriological and serological methods in detection of this type of pathogens. The aim of this study was to achieve a more specific antigen for serological tests.
Materials and methods: Blood samples were taken from 192 women with suspected chlamydial infection and sera were isolated. ELISA plate wells were coated with recombinant C. trachomatis OMP2 as antigen. Cut-off system was determined with 40 negative sera. The final results of this research were compared with Euroimmun commercial kit.
Results: The ELISA system cut-off was calculated at 0.27 using negative sera samples. ODs of positive samples were higher than 0.27 and negative samples were lower than it. We obtained 30 samples (15.62%) as positive and 162 cases (84.37%) as negative. Sensitivity and specificity of the recombinant antigen were 90% and 86%, respectively. This antigen showed no cross-reactivity with sera of patients infected with Hydatid cyst, HCV, Epstein barr virus, HBV, Helicobacter pylori, Toxoplasma gondii, Cytomegalovirus, Mycoplasma, Measles and Varicella zoster virus.
Conclusion: The sensitivity and specificity of rOMP2 in ELISA for detection of C. trachomatis were 90% and 86%, respectively. Though the sensitivity was higher than results of Euroimmun commercial kit, its specificity was calculated lower than reference kit.
Keywords: Chlamydia trachomatis; ELISA; OMP2.
Figures





Similar articles
-
Cloning, expression and purification of truncated Chlamydia trachomatis outer membrane protein 2 (omp2) and its application in an ELISA assay.Iran J Immunol. 2008 Sep;5(3):148-55. Iran J Immunol. 2008. PMID: 18791281
-
Mixed Chlamydia trachomatis Peptide Antigens Provide a Specific and Sensitive Single-Well Colorimetric Enzyme-Linked Immunosorbent Assay for Detection of Human Anti-C. trachomatis Antibodies.mSphere. 2018 Nov 7;3(6):e00484-18. doi: 10.1128/mSphere.00484-18. mSphere. 2018. PMID: 30404936 Free PMC article.
-
Discovery of Human-Specific Immunodominant Chlamydia trachomatis B Cell Epitopes.mSphere. 2018 Aug 1;3(4):e00246-18. doi: 10.1128/mSphere.00246-18. mSphere. 2018. PMID: 30068558 Free PMC article.
-
[Development of serodiagnostic kit "HITAZYME Chlamydia Ab" for Chlamydia trachomatis infections using extracted antigen].Kansenshogaku Zasshi. 1992 May;66(5):584-91. doi: 10.11150/kansenshogakuzasshi1970.66.584. Kansenshogaku Zasshi. 1992. PMID: 1383356 Japanese.
-
Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.Clin Microbiol Infect. 2010 Aug;16(8):1237-44. doi: 10.1111/j.1469-0691.2009.03041.x. Epub 2009 Sep 1. Clin Microbiol Infect. 2010. PMID: 19723133
References
-
- Anestad G, Lunde O, Moen M, Dalaker K. Infertility and chlamydial infection. Fertil Steril. 1987;48:787–790. - PubMed
-
- Davis B. Microbiology. 4. Lippincott; 1990.
-
- Cliff B, Tabrizi S, Sullivan EA. Chlamydia in the Pacific region, the silent epidemic. Sex Transm Dis. 2008;35:801–680. - PubMed
-
- Kane JL, Woodland RM, Forsey T, Darougar S, Elder MG. Evidence of chlamydia infection in infertile women with and withour fallopian tube obstruction. Fertile Steril. 1984:843–848. - PubMed
-
- Binns B, Wiliams T, McDowell J, Brunham RC. Screening for Chlamydia trachomatis infection in pregnancy counseling clinic. Am J Obstet Gynecol. 1988;159:1144–1149. - PubMed
LinkOut - more resources
Full Text Sources